Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zoetis (NY:ZTS)

118.63 -1.16 (-0.97%)
Streaming Delayed Price Updated: 11:51 AM EDT, Mar 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Zoetis

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Zoetis to Participate in the KeyBanc Capital Markets Healthcare Forum
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis to Participate in Upcoming Investor Conferences
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis to Acquire Animal Genomics Business from Neogen®, Accelerating Precision Animal Health Innovation
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis to Participate in the Bank of America Securities 2026 Animal Health Summit
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Reports Fourth Quarter and Full Year 2025 Results
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Declares Second Quarter 2026 Dividend
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2025 Financial Results
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis to Participate in the 44th Annual J.P. Morgan Healthcare Conference
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis to Participate in the Piper Sandler 37th Annual Healthcare Conference
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis to Host Innovation Webcast
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Announces Third Quarter 2025 Results
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Announces Retirement of Rob Polzer at the End of 2025 and the Appointment of Kevin Esch as President of Research & Development for World Leader in Animal Health Beginning in 2026
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Receives European Commission Marketing Authorization for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Appoints Stephanie Tilenius to its Board of Directors
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Declares Fourth Quarter 2025 Dividend
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis to Host Webcast and Conference Call on Third Quarter 2025 Financial Results
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Receives Positive Opinion from CVMP for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Announces Pricing of $1.85 Billion of Senior Notes
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis Announces Second Quarter 2025 Results, Raises Full Year 2025 Outlook
From Zoetis Inc.
Via Business Wire
News headline image
Zoetis to Host Webcast and Conference Call on Second Quarter 2025 Financial Results
From Zoetis Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.